OPTimizing Treatment Focused Genetic Testing IN Advanced Cancer- OPT-IN

NOT ENROLLING
Protocol # :
19-068
Conditions
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Phase
Not Applicable
Disease Sites
Neuroendocrine/Carcinoid
Gastroesophageal Junction
Gallbladder/Biliary
Lip, Oral Cavity and Pharynx
Esophagus
Stomach
Small Intestine
Colon
Rectum
Anus
Liver
Pancreas
Other Digestive Organ
Larynx
Lung
Other Respiratory and Intrathoracic Organs
Bones and Joints
Soft Tissue
Mycosis Fungoides
Other Skin
Breast
Cervix
Corpus Uteri
Ovary
Other Female Genital
Prostate
Other Male Genital
Urinary Bladder
Kidney
Other Urinary
Eye and Orbit
Brain and Nervous System
Thyroid
Other Hematopoietic
Unknown Sites
Ill-Defined Sites
Other Endocrine System
Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Multiple Myeloma
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Kaposi's Sarcoma
Melanoma, Skin
Principal Investigator
Rana, Huma
Site Investigator
Sanz- Altamira, Pedro
Site Research Nurses
Brule, Maurice, N.
Gentile, Alissa

Trial Description

This two-part randomized controlled trial aims to evaluate the impact of pre-test video
education as compared to pre-test Chatbot education.

Eligibility Requirements

Inclusion Criteria:

- Adult patients over the age of 18

- With a diagnosis of advanced cancer (defined as Stage 3 or 4), or

- Any stage for pancreatic cancer and

- No prior cancer genetic panel testing

Exclusion Criteria:

- Adults unable to consent

- Individuals who are not yet adults (infants, children, teenagers)

- Pregnant women (if known at the time of participation)

- Prisoners

- Non-English speakers

19-068